46
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

A newly developed UPLC-MS/MS method for simultaneous quantitative analysis of ajuforrestin A, ajuforrestin B, ajugamacrin and 8-O-acetylharpagide derived from Ajuga plants in mice blood and the in vivo pharmacokinetics

, , , , , & ORCID Icon show all
Pages 354-362 | Received 21 Jul 2023, Accepted 05 Mar 2024, Published online: 14 Mar 2024

References

  • Wang H, Teng X, Zhang Y, et al. Diterpenoids from the whole plants of ajuga nipponensis and their inhibition of RANKL-Induced osteoclastogenesis. Chem Biodivers. 2021;18(1):e2000780. doi: 10.1002/cbdv.202000780.
  • Israili ZH, Lyoussi B. Ethnopharmacology of the plants of genus ajuga. Pak J Pharm Sci. 2009;22(4):425–462.
  • Popova E, Titova M, Tynykulov M, et al. Sustainable production of ajuga bioactive metabolites using cell culture technologies: a review. Nutrients. 2023;15(5):1246. doi: 10.3390/nu15051246.
  • Luan F, Han K, Li M, et al. Ethnomedicinal uses, phytochemistry, pharmacology, and toxicology of species from the genus ajuga L.: a systematic review. Am J Chin Med. 2019;47(5):959–1003. doi: 10.1142/s0192415x19500502.
  • Hsu WH, Lin BZ, Leu JD, et al. Involvement of 8-O-acetylharpagide for ajuga taiwanensis mediated suppression of senescent phenotypes in human dermal fibroblasts. Sci Rep. 2020;10(1):19731. doi: 10.1038/s41598-020-76797-6.
  • Wang YC, Yang YY, Chi DF. Transcriptome analysis of abscisic acid induced 20E regulation in suspension ajuga lobata cells. 3 Biotech. 2018;8(8):320. doi: 10.1007/s13205-018-1352-6.
  • Zhang Y, Tang H, Zheng Y, et al. Optimization of ultrasound-assisted extraction of poly-phenols from ajuga ciliata bunge and evaluation of antioxidant activities in vitro. Heliyon. 2019;5(10):e02733. doi: 10.1016/j.heliyon.2019.e02733.
  • Zacchaeus Olatunde O, Yong J, Lu C. New neo-Clerodane diterpenoids isolated from ajuga decumbens thunb., planted at pingtan island of Fujian province with the potent anticancer activity. Anticancer Agents Med Chem. 2023;23(2):237–244. doi: 10.2174/1871520622666220620151225.
  • Wang Y, Liu YC, Li WY, et al. Antifeedant, cytotoxic, and anti-inflammatory neo-clerodane diterpenoids in the peltate glandular trichomes and fresh leaves of ajuga forrestii. Phytochemistry. 2021;186:112731. doi: 10.1016/j.phytochem.2021.112731.
  • Dong B, Yang X, Liu W, et al. Anti-inflammatory neo-Clerodane diterpenoids from ajuga pantantha. J Nat Prod. 2020;83(4):894–904. doi: 10.1021/acs.jnatprod.9b00629.
  • Castro A, Coll J, Pant AK, et al. Neo-Clerodane diterpenoids from ajuga macrosperma var. breviflora. Nat Prod Commun. 2015;10(6):857–860.
  • Wang KJ, Bao TR, Yang YC, et al. Five previously undescribed compounds from ajuga lupulina maxim. and 38(their in vitro activities. Nat Prod Res. 2024;3):503–511. doi: 10.1080/14786419.2022.2130305.
  • Shaukat B, Mehmood MH, Murtaza B, et al. Ajuga bracteosa exerts antihypertensive activity in l-NAME-induced hypertension possibly through modulation of oxidative stress, proinflammatory cytokines, and the nitric oxide/cyclic guanosine monophosphate pathway. ACS Omega. 2022;7(37):33307–33319. doi: 10.1021/acsomega.2c03888.
  • Lee Y, Kim HM, Kim JH, et al. Chemical constituents of the ajuga multiflora bunge and their protective effects on dexamethasone-induced muscle atrophy in C2C12 myotubes. Nat Prod Res. 2023;37(12):1978–1985. doi: 10.1080/14786419.2022.2115491.
  • Yan H, Jiang M, Yang F, et al. Ajuforrestin A, an abietane diterpenoid from ajuga ovalifolia var. calanthe, induces A549 cell apoptosis by targeting SHP2. Molecules. 2022;27(17):5469. doi: 10.3390/molecules27175469.
  • Takasaki M, Tokuda H, Nishino H, et al. Cancer chemopreventive agents (antitumor-promoters) from ajuga decumbens. J Nat Prod. 1999;62(7):972–975. doi: 10.1021/np990033w.
  • Konoshima T, Takasaki M, Tokuda H, et al. Cancer chemopreventive activity of an iridoid glycoside, 8-acetylharpagide, from ajuga decumbens. Cancer Lett. 2000;157(1):87–92. doi: 10.1016/s0304-3835(00)00479-1.
  • Bermejo P, Abad MJ, Díaz AM, et al. Antiviral activity of seven iridoids, three saikosaponins and one phenylpropanoid glycoside extracted from bupleurum rigidum and scrophularia scorodonia. Planta Med. 2002;68(2):106–110. doi: 10.1055/s-2002-20238.
  • Abdel-Kader MS, Alqasoumi SI. In vivo hepatoprotective and nephroprotective activity of acylated iridoid glycosides from scrophularia hepericifolia. Biology (Basel). 2021;10(2):145. doi: 10.3390/biology10020145.
  • Bermejo Benito P, Díaz Lanza AM, Silván Sen AM, et al. Effects of some iridoids from plant origin on arachidonic acid metabolism in cellular systems. Planta Med. 2000;66(4):324–328. doi: 10.1055/s-2000-8549.
  • He GX, Liang XL, Ouyang W, et al. Chemical constituents from ajuga nipponensis. Zhong Yao Cai. 2013;36(12):1950–1953.
  • Gong M, Chen L, Li J, et al. Content determination of harpagide and acetylharpagide in ajugamedicinal materials. Hunan J Trad Chin Med. 2017;33(5):172–174.
  • Yue DK, Ding GZ, Wang WH, et al. Determination of acetylharpagide in ajuga decumbens by HPLC. Zhongguo Zhong Yao Za Zhi. 2006;31(4):289–290.
  • Remeur C, Le Borgne E, Gauthier L, et al. HPLC-ELSD quantification and centrifugal partition chromatography isolation of 8-O-acetylharpagide from oxera coronata (lamiaceae). Phytochem Anal. 2017;28(3):242–246. doi: 10.1002/pca.2667.
  • Pitschmann A, Zehl M, Heiss E, et al. Quantitation of phenylpropanoids and iridoids in insulin-sensitising extracts of leonurus sibiricus L. (lamiaceae). Phytochem Anal. 2016;27(1):23–31. doi: 10.1002/pca.2583.
  • Wen B, He R, Li P, et al. Pharmacokinetics of 8-O-acetylharpagide and harpagide after oral administration of ajuga decumbens thunb extract in rats. J Ethnopharmacol. 2013;147(2):503–508. doi: 10.1016/j.jep.2013.03.048.
  • Wen BY, Li JR. Pharmacokinetics of 8-O-acetylharpagide and harpagide after oral administration of ajuga decumbens extract in beagle dog. Zhongguo Zhong Yao Za Zhi. 2013;38(12):2015–2018.
  • Chan YY. Neoclerodane diterpenoids from ajuga taiwanensis. Chem Pharm Bull (Tokyo). 2005;53(2):164–167. doi: 10.1248/cpb.53.164.
  • Services UDoHaH. Guidance for Industry: Bioanalytical Method Validation. F.A.D.A. US Department of Health and Human Services, Washington, DC, USA. 2013.
  • Wang X, Zheng M, Liu J, et al. Differences of first-pass effect in the liver and intestine contribute to the stereoselective pharmacokinetics of rhynchophylline and isorhynchophylline epimers in rats. J Ethnopharmacol. 2017;209:175–183. doi: 10.1016/j.jep.2017.07.039.
  • Zhang J, Xie J, Liang Y, et al. Anxiolytic effects, metabolism and plasma pharmacokinetics of 3, 6’-disinapoylsucrose. Biomed Pharmacother. 2022;149:112913. doi: 10.1016/j.biopha.2022.112913.
  • Chen L, Zhang B, Liu J, et al. Pharmacokinetics and bioavailability study of monocrotaline in mouse blood by ultra-performance liquid chromatography-tandem mass spectrometry. Biomed Res Int. 2018;2018:1578643–1578610. doi: 10.1155/2018/1578643.
  • Khatibi SA, Hamidi S, Siahi-Shadbad MR. Application of liquid-liquid extraction for the determination of antibiotics in the foodstuff: recent trends and developments. Crit Rev Anal Chem. 2022;52(2):327–342. doi: 10.1080/10408347.2020.1798211.
  • Li Y, Dano R, Li C, et al. Pharmacokinetic and brain distribution study of an anti-glioblastoma agent in mice by HPLC-MS/MS. Biomed Chromatogr. 2022;36(3):e5310. doi: 10.1002/bmc.5310.
  • Zhou L, Yan K, Xing S, et al. Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6. Open Med (Wars). 2023;18(1):20230680. doi: 10.1515/med-2023-0680.
  • Li J, Xu Z, Gu J. UGT1A1 and UGT1A9 are responsible for phase II metabolism of tectorigenin and irigenin in vitro. Molecules. 2022;27(13):4104. doi: 10.3390/molecules27134104.
  • Su XL, Lin RC, Wong SK, et al. Identification and characterisation of the Chinese herb langdu by LC-MS/MS analysis. Phytochem Anal. 2003;14(1):40–47. doi: 10.1002/pca.685.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.